Tonix Pharmaceuticals Holding Corp (NAS:TNXP)
$ 0.1975 0.0159 (8.76%) Market Cap: 18.87 Mil Enterprise Value: 2.23 Mil PE Ratio: 0 PB Ratio: 0.15 GF Score: 34/100

Tonix Pharmaceuticals Holding Corp at ThinkEquity Conference Transcript

Oct 26, 2022 / 02:30PM GMT
Release Date Price: $3.06 (-1.84%)
Nick Christian
ThinkEquity LLC - Analyst

My name is Nick Christian. I'm with ThinkEquity. Our next presenting company is Tonix Pharmaceuticals, so I'll turn it over to them.

Jessica Morris
Tonix Pharmaceuticals Holding Corp. - COO

Hi. Thank you very much. Thank you to ThinkEquity for having Tonix at this conference, and welcome to everyone in person and also attending via webcast. I am Jessica Morris, the Chief Operating Officer with Tonix Pharmaceuticals.

Tonix is a publicly traded company. We're traded on NASDAQ under the ticker TNXP. So here is our standard Safe Harbor statement. I will be making forward-looking statements, and I refer you to our SEC filings for complete information.

So Tonix is a clinical-stage biopharmaceutical company. And ultimately our mission, our vision is to invent and develop new innovative therapies as well as new vaccines for people in need around the world. And how do we propose to do that? This is covered in our investment highlights. So I'll start at the top.

We have a diverse and robust pipeline

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot